Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-24-026629

EVP R&D, Chief Medical Officer sold 10,471 shares at $29.53 ($309,169)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-06 Sale : show line 1 in the form 10b5-1 −10,471 $29.53 $309,169 99,238 D
Open-market sales · 10,471 sh · avg $29.53 · $309,169
Loading xslF345X05/form4.xml…